BIBF 1120 (Nintedanib), a triple angiokinase inhibitor, induces hypoxia but not EMT and blocks progression of preclinical models of lung and pancreatic cancer

Por Cenik, Bercin Kutluk, Ostapoff, Katherine T., Gerber, David E., Brekken, Rolf A.
Publicado em 2013

Axillary lymph node dissection for breast cancer utilizing Harmonic Focus(®)

Por Ostapoff, Katherine T, Euhus, David, Xie, Xian-Jin, Rao, Madhu, Moldrem, Amy, Rao, Roshni
Publicado em 2011

Epithelial–mesenchymal transition increases tumor sensitivity to COX-2 inhibition by apricoxib

Por Kirane, Amanda, Toombs, Jason E, Larsen, Jill E, Ostapoff, Katherine T, Meshaw, Kathryn R, Zaknoen, Sara, Brekken, Rolf A, Burrows, Francis J
Publicado em 2012

Tris DBA palladium is highly effective against growth and metastasis of pancreatic cancer in an orthotopic model

Por Díaz, Begoña, Ostapoff, Katherine T., Toombs, Jason E., Lo, Jason, Bonner, Michael Y., Curatolo, Adam, Adsay, Volkan, Brekken, Rolf A., Arbiser, Jack L.
Publicado no Oncotarget (2016)

Apricoxib, a Novel Inhibitor of COX-2, Markedly Improves Standard Therapy Response in Molecularly Defined Models of Pancreatic Cancer

Por Kirane, Amanda, Toombs, Jason E., Ostapoff, Katherine, Carbon, Juliet G., Zaknoen, Sara, Braunfeld, Jordan, Schwarz, Roderich E., Burrows, Francis J., Brekken, Rolf A.
Publicado em 2012

Neutralizing murine TGFβR2 promotes a differentiated tumor cell phenotype and inhibits pancreatic cancer metastasis

Por Ostapoff, Katherine T., Cenik, Bercin Kutluk, Wang, Miao, Ye, Risheng, Xu, Xiaohong, Nugent, Desiree, Hagopian, Moriah M., Topalovski, Mary, Rivera, Lee B., Carroll, Kyla D., Brekken, Rolf A.
Publicado em 2014